Pilot Extension for Individual Patient Input to the Common Drug Review
The Common Drug Review (CDR) is extending its pilot to receive patient input submissions from individual patients and caregivers until August 3, 2015.
Pilot Extension for Patient Input for Therapeutic Reviews
CADTH implemented a pilot process for receiving patient input submissions for ... Read More
04
Feb2015
04
Feb2015
PMPRB
The PMPRB has released its January 2015 NEWSletter
Topics covered in the NEWSletter include:
Final 2014 CPI-Based Price-Adjustment Factors: The final CPI figures for 2014 are now available. Of note:
The actual CPI-based price-adjustment factor for 2 year (2012) and 3 year (2011) are lower than forecast. As a result, some manufacturers/patentees may ... Read More
14
Jan2015
QUEBEC
L’Institut national d’excellence en santé et en services sociaux (INESSS) has released the list of drug products submitted for the June 2015 “Liste des médicaments.”
Health professionals, citizens and patients and their associations and groups have until ... Read More
05
Jan2015
Common Drug Review
The Canadian Agency for Drugs and Technologies in Health posted the Canadian Drug Expert Committee (CDEC) final recommendation for its first review of a subsequent entry biologic on its website yesterday. Below is an excerpt from the CDEC Final Recommendation.
Recommendation: ... Read More
22
Dec2014
Please note that our office will be closed from December 25, 2014 to January 2, 2015, inclusive.
14
Nov2014
Included in this edition are:
PMPRB Town Hall Meeting
PMPRB Staff held a Town Hall meeting on October 1 at the Ottawa Convention Centre. Discussions involved PMPRB Staff taking a fresh look at the organization’s vision and mandate, potential new strategic priorities for the PMPRB and how to operationalize them moving forward. ... Read More
06
Nov2014
ONTARIO
Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products
An Ontario Public Drug Programs Executive Officer Communication published on November 5, 2014 invites stakeholder comments on proposed amendments to O. Reg. 201/96 under the Ontario Drug Benefit Act. The proposed amendments would establish a pricing framework for ... Read More
03
Nov2014
Date Posted:
November 3, 2014
Location:
Ottawa, Ontario
Job Title:
Pricing & Market Access Associate
Reports To:
Director, Pricing & Market Access
Employment Type:
Full-time
Website:
pdci.ca/about-us/careers/
For more information regarding this position or any other career opportunities with PDCI, please visit our careers page.
03
Nov2014
PMPRB
The Chairperson of the Board has approved a Voluntary Compliance Undertaking submitted by Valeant Canada LP regarding the price of Lodalis (colesevelam hydrochloride).
For more information regarding the VCU, please consult the PMPRB website.
24
Oct2014
The next PMPRB OUTREACH Sessions will be held on Tuesday, December 2, 2014 in Montreal, followed by Wednesday, December 3, 2014 in Toronto.
Rumoured topics to be covered include:
Changes to current international price source formularies referenced by Board Staff (specifically Germany)
Supplementary price sources
Updates on Form 2 regulatory amendments undergoing Canada Gazette ... Read More